XTL Biopharmaceuticals Ltd. (XTLB) Debt by Year

XTLB NASDAQ

XTL Biopharmaceuticals Ltd. held $76K in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters XTL Biopharmaceuticals Ltd. has filed alongside them.

FY2025 annual

Long-Term Debt N/A

Cash & Equivalents $76K

Source SEC Filings (20-F/6-K) Latest period FY2025, ended Dec 31, 2025 Reported Jun 30, 2026 Currency USD

Annual figures, oldest first. Point at a bar to read its period.

XTLB Debt & Cash by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

Metric	FY2520-F	FY2420-F	FY2320-F	FY2220-F	FY2120-F	FY2020-F	FY1920-F	FY1820-F	FY1720-F	FY1620-F	FY1520-F
Long-Term Debt	N/A	$138K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$76K-79.5%	$371K-73.5%	$1.4M-33.1%	$2.1M-29.5%	$3.0M-18.2%	$3.6M-18.5%	$4.5M+36.9%	$3.3M-1.0%	$3.3M+62.9%	$2.0M-47.1%	$3.8M

XTLB Debt & Cash by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

Metric	Q4'2420-F	Q3'2420-F	Q4'2320-F	Q4'2220-F	Q2'226-K	Q4'2120-F	Q2'216-K	Q4'2020-F	Q2'206-K	Q4'1920-F	Q4'1820-F	Q4'1720-F
Long-Term Debt	$138K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$371K-73.5%	N/A	$1.4M-33.1%	$2.1M-29.5%	$2.3M-19.6%	$3.0M-18.2%	$2.9M-27.5%	$3.6M-18.5%	$4.0M	$4.5M+36.9%	$3.3M-1.0%	$3.3M+62.9%

XTLB files its annual report on Form 20-F and its quarterly results on Form 6-K, and SEC's XBRL data holds no figures from those 6-K reports, so the quarterly figures here stop at the quarter ended December 31, 2024, while the annual figures run through FY2025.

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More XTL Biopharmaceuticals Ltd. financials

Frequently Asked Questions

What was XTL Biopharmaceuticals Ltd.'s long-term debt in fiscal year 2025?

XTL Biopharmaceuticals Ltd. held $76K in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period.

What was XTL Biopharmaceuticals Ltd.'s long-term debt in the most recent quarter?

XTL Biopharmaceuticals Ltd. (XTLB) reported $138K in long-term debt in Q4 2024.

What does long-term debt mean on a financial statement?

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what XTL Biopharmaceuticals Ltd. (XTLB) reported on that line in every period on record.